Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexamethasone + Hydroxychloroquine for COVID-19 ARDS
NCT04347980Phase 3Terminated
- Sponsor
- Hôpital Marie-Lannelongue
- Start
- Apr 2020
- Primary completion
- Aug 2020
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of dexamethasone in coronavirus disease 2019 (COVID-19), acute respiratory distress syndrome (ARDS), sponsored by Hôpital Marie-Lannelongue. Started Apr 2020; status: terminated.
02
Drugs
dexamethasone
03
Conditions
coronavirus disease 2019 (COVID-19)acute respiratory distress syndrome (ARDS)
Beyond the preview
Go deeper on NCT04347980.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04347980.